ATE114674T1 - Oligosaccharide von heparin mit einer affinität für faktoren von zellwachstum. - Google Patents

Oligosaccharide von heparin mit einer affinität für faktoren von zellwachstum.

Info

Publication number
ATE114674T1
ATE114674T1 AT87400884T AT87400884T ATE114674T1 AT E114674 T1 ATE114674 T1 AT E114674T1 AT 87400884 T AT87400884 T AT 87400884T AT 87400884 T AT87400884 T AT 87400884T AT E114674 T1 ATE114674 T1 AT E114674T1
Authority
AT
Austria
Prior art keywords
cell growth
affinity
growth factors
possessing
heparin oligosaccharides
Prior art date
Application number
AT87400884T
Other languages
English (en)
Inventor
Jean-Claude Lormeau
Maurice Petitou
Jean Choay
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE114674T1 publication Critical patent/ATE114674T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87400884T 1986-04-17 1987-04-16 Oligosaccharide von heparin mit einer affinität für faktoren von zellwachstum. ATE114674T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8605546A FR2597484B1 (fr) 1986-04-17 1986-04-17 Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.

Publications (1)

Publication Number Publication Date
ATE114674T1 true ATE114674T1 (de) 1994-12-15

Family

ID=9334346

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87400884T ATE114674T1 (de) 1986-04-17 1987-04-16 Oligosaccharide von heparin mit einer affinität für faktoren von zellwachstum.

Country Status (8)

Country Link
US (1) US5034520A (de)
EP (1) EP0244298B1 (de)
JP (1) JPS6366192A (de)
AT (1) ATE114674T1 (de)
CA (1) CA1339925C (de)
DE (1) DE3750785T2 (de)
FR (1) FR2597484B1 (de)
PT (1) PT84719B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273900A (en) * 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
MX9201801A (es) * 1991-04-16 1992-10-30 Seikagaku Kogyo Co Ltd Oligosacarido que tiene afinidad para el factor de desarrollo del fibroplasto y procedimiento para producirlo.
US5145956A (en) * 1991-12-11 1992-09-08 Glycomed Incorporated Method for separation of anionic oligosaccharides
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
GB2266239B (en) * 1992-03-25 1996-03-06 Jevco Ltd Wound healing compositions containing chondroitin sulphate oligosaccharides
US6750207B1 (en) 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
US5861382A (en) * 1992-05-01 1999-01-19 Yeda Research And Development Co. Ltd. Methods for regulation of active TNF-α
FR2691066B1 (fr) * 1992-05-15 1995-06-09 Sanofi Elf Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
CA2149116A1 (en) * 1992-11-10 1994-05-26 Irun R. Cohen Compositions for the regulation of cytokine activity
GB9306255D0 (en) * 1993-03-25 1993-05-19 Cancer Res Campaign Tech Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity
US6127347A (en) * 1994-01-12 2000-10-03 Univ Michigan Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
US5583121A (en) * 1994-01-12 1996-12-10 Michigan State University Non-anticoagulant chemically modified heparinoids for treating hypovolemic shock and related shock syndromes
WO1996023003A1 (en) * 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
AU702500B2 (en) * 1995-04-28 1999-02-25 Australian National University, The Preparation and use of sulfated oligosaccharides
AUPN261895A0 (en) * 1995-04-28 1995-05-18 Australian National University, The Preparation and use of sulfated oligosaccharides
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
WO1999004801A1 (en) * 1997-07-28 1999-02-04 Rijks Universiteit Leiden Use of sulfated glycosaminoglycans for treating of retinopathy
DE19747195A1 (de) * 1997-10-24 1999-04-29 Knoll Ag Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
JP4633232B2 (ja) * 2000-06-22 2011-02-16 生化学工業株式会社 成長因子誘導剤
AU2002236477A1 (en) * 2000-11-21 2002-06-03 The Texas A & M University System Fgf-affinity chromatography
US7285536B2 (en) * 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
WO2005079817A1 (en) * 2004-02-18 2005-09-01 The Texas A & M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the fgf receptor
US20060293275A1 (en) * 2004-03-29 2006-12-28 Toshikazu Nakamura Hgf production accelerator containing heparin-like oligosaccharide
US20060183712A1 (en) * 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
EP2356128A1 (de) * 2008-09-15 2011-08-17 Endotis Pharma Oligosaccharidverbindungen zur verwendung bei der mobilisierung von stammzellen
FR2949115B1 (fr) * 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
CA1226816A (en) * 1982-12-20 1987-09-15 Moses J. Folkman Inhibition of angiogenesis
FR2553287B1 (fr) * 1983-10-18 1986-09-12 Choay Sa Compositions a base de mucopolysaccharides ou d'oligosaccharides, notamment a base de fractions ou fragments d'heparine, appropriees au traitement de desordres de la proliferation cellulaire
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation

Also Published As

Publication number Publication date
FR2597484B1 (fr) 1988-12-23
PT84719A (fr) 1987-05-01
EP0244298B1 (de) 1994-11-30
DE3750785D1 (de) 1995-01-12
FR2597484A1 (fr) 1987-10-23
EP0244298A3 (en) 1988-09-21
PT84719B (pt) 1989-12-29
JPS6366192A (ja) 1988-03-24
EP0244298A2 (de) 1987-11-04
US5034520A (en) 1991-07-23
DE3750785T2 (de) 1995-06-22
CA1339925C (fr) 1998-06-23

Similar Documents

Publication Publication Date Title
DE3750785D1 (de) Oligosaccharide von Heparin mit einer Affinität für Faktoren von Zellwachstum.
DE59005283D1 (de) Adaptierbarer schaft für eine endoprothese.
DE68912249D1 (de) Einrichtung für Wartungsarbeiten, insbesondere für das Waschen von Isolatorketten an Hochspannungsleitungen.
DE3775359D1 (de) Pruefung von photodioden mit elektronenstrahlen.
DE69020555D1 (de) Fällungstest für mikroorganismen.
NO910996D0 (no) Blekepreparat, samt fremgangsmaate for bleking.
FI873719L (fi) Alkoxisilanterminala, i fukt haerdande polyuretaner, samt deras anvaendning i lim- och taetningsmassor.
ES513896A0 (es) "un procedimiento para preparar hidrogeles que retienen la forma a base de colageno solubilizado, utiles por ejemplo para fines medicos y cosmeticos".
DE3750899D1 (de) Polymer für Toner, dessen Herstellungsverfahren und Tonerzusammensetzung.
DE3767905D1 (de) Abnehmbahrer zapfen, insbesondere fuer das hebelwerk von textilmaschinen.
DE58907577D1 (de) Gleitlack für Elastomerteile.
DE69009380D1 (de) Chloroprenpolymerisat.
DE69020360D1 (de) Zusammensetzung eines elektrolyten auf basis von ceroxid.
FI843498A0 (fi) Med polyisocyanatblandningar limmade papperprodukter.
ATE86490T1 (de) Tracheobronchodilatator.
DE69000546D1 (de) Dampferzeuger mit vorwaermung.
DE3854006D1 (de) Generator von periodischen Signalen, insbesondere für Schaltnetzteile.
DE69421921D1 (de) Verzweigtes Polysaccharide, es produzierender Mikroorganismus und Zusammensetzungen welche sie enthalten
ES2093458T3 (es) Procedimiento para la obtencion de 1,1,1,3,3-pentafluorpropano.
DE69009913D1 (de) Kationische Elektrotauchlackierzusammensetzung.
DE68916969D1 (de) Prüfung von elektrischen kreisen.
DE3870557D1 (de) Drehzylinder mit stiften fuer eine textilmaschine, einen oeffner, zerfaserungs-, reiss-maschine oder aehnliches.
DE3750854D1 (de) Iterativer, in Echtzeit arbeitender XY-Rasterpfadgenerator für begrenzte Gebiete.
DE68922304D1 (de) Scharnierverschluss für behälter.
DE3778616D1 (de) Heparin-testverfahren.